You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-HER2 (ERBB2) Antibodies

Full name:
anti-V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian) Antibodies (ERBB2)
On www.antibodies-online.com are 1517 V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian) (ERBB2) Antibodies from 43 different suppliers available. Additionally we are shipping HER2 Proteins (83) and HER2 Kits (43) and many more products for this protein. A total of 1725 HER2 products are currently listed.
Synonyms:
c-erbB2, c-neu, CD340, Erbb-2, HER-2, HER-2/neu, HER2, mKIAA3023, MLN 19, Neu, NGL, TKR1
list all antibodies Gene Name GeneID UniProt
ERBB2 24337  
ERBB2 2064 P04626
ERBB2 13866 P70424

Show all species

Show all synonyms

All available anti-HER2 Antibodies

Go to our pre-filtered search.

Top referenced anti-HER2 Antibodies

  1. Human Monoclonal HER2 Primary Antibody for IHC (p) - ABIN1688892 : Savci-Heijink, Halfwerk, Hooijer, Horlings, Wesseling, van de Vijver: Retrospective analysis of metastatic behaviour of breast cancer subtypes. in Breast cancer research and treatment 2015 (PubMed)
    Show all 50 references for ABIN1688892

  2. Human Monoclonal HER2 Primary Antibody for IF, IHC (p) - ABIN180514 : DiGiovanna, Stern: Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor. in Cancer research 1995 (PubMed)
    Show all 11 references for ABIN180514

  3. Human Polyclonal HER2 Primary Antibody for IHC (p), WB - ABIN391947 : Ehsani, Low, Wallace, Wu: Characterization of a new allele of the human ERBB2 gene by allele-specific competition hybridization. in Genomics 1993 (PubMed)
    Show all 4 references for ABIN391947

  4. Human Polyclonal HER2 Primary Antibody for EIA, FACS - ABIN359840 : Yamamoto, Ikawa, Akiyama, Semba, Nomura, Miyajima, Saito, Toyoshima: Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. in Nature 1986 (PubMed)
    Show all 4 references for ABIN359840

  5. Human Polyclonal HER2 Primary Antibody for FACS, IHC (p) - ABIN391945 : Coussens, Yang-Feng, Liao, Chen, Gray, McGrath, Seeburg, Libermann, Schlessinger, Francke: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. in Science (New York, N.Y.) 1985 (PubMed)
    Show all 4 references for ABIN391945

  6. Human Polyclonal HER2 Primary Antibody for IF, ELISA - ABIN1531590 : King, Kraus, Aaronson: Amplification of a novel v-erbB-related gene in a human mammary carcinoma. in Science (New York, N.Y.) 1985 (PubMed)
    Show all 3 references for ABIN1531590

  7. Human Polyclonal HER2 Primary Antibody for IHC (fro), IHC (p) - ABIN115291 : Schechter, Hung, Vaidyanathan, Weinberg, Yang-Feng, Francke, Ullrich, Coussens: The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. in Science (New York, N.Y.) 1985 (PubMed)
    Show all 3 references for ABIN115291

More Antibodies against HER2 Interaction Partners

Human V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian) (ERBB2) interaction partners

  1. A role for Her2/neu in identifying high-risk patients for malignant transformation.

  2. A trend of decreasing Her2/neu expression with increasing grade of tumor was observed.

  3. In breast cancer patients treated with trastuzumab, the germline Ala1170Pro homozygous ERBB2 genotype was associated with a lower likelihood of the occurrence of a cardiac event compared with Pro/Pro + Ala/Pro genotypes.

  4. HER2 mutations are rare in HER2-positive Japanese breast cancer patients.

  5. Breast cancer patients with HER2 equivocal status have no significantly higher risk of recurrence.

  6. Overexpression of HER-2 with high level of PSA (show PLAG1 Antibodies) are associated with prostatic adenocarcinoma.

  7. HER2 gene amplification is associated with breast cancer.

  8. miR (show MLXIP Antibodies)-34a, like ErbB2, might be a diagnostic target in breast cancer.

  9. This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options

  10. HER2-positive tumors in our study had a lower Ki-67 (show MKI67 Antibodies) index and were p53 (show TP53 Antibodies)-positive.

Mouse (Murine) V-Erb-B2 erythroblastic Leukemia Viral Oncogene Homolog 2, Neuro/glioblastoma Derived Oncogene Homolog (Avian) (ERBB2) interaction partners

  1. It was suggested that transgenic HER-2/neu involves in initiation of malignization of mammary epithelial cells but also in acceleration of age-related hormonal and metabolic changes in turn promoting mammary carcinogenesis

  2. Study showed that suppression of STAT3 (show STAT3 Antibodies), STAT5 (show STAT5A Antibodies), and STAT6 (show STAT6 Antibodies) and overexpression of the proapoptotic factor STAT1 (show STAT1 Antibodies), which provides p53 (show TP53 Antibodies)-mediated apoptosis, are the causes for increasing the number of apoptotic neurons in physiological aging. HER-2 tyrosine kinase receptor (show KDR Antibodies) overexpression promotes neuronal survival through activation of STAT (show STAT1 Antibodies)-signaling pathway with simultaneous suppression of the proapoptotic factor STAT1 (show STAT1 Antibodies)

  3. that myocardial ErbB2 and beta-adrenergic receptors signalling are linked in a feedback loop with beta-adrenergic receptors activation leading to increased ErbB2 expression and activity

  4. Metformin inhibits breast tumor angiogenesis and suggest role of HIF-1alpha (show HIF1A Antibodies)-VEGF (show VEGFA Antibodies) signaling axis in mediating HER2-induced tumor angiogenesis.

  5. In trastuzumab-doxorubicin combination therapy in a murine model of HER2+ breast cancer.

  6. Data indicate that Sonic hedgehog (Shh (show SHH Antibodies)) stimulate branching morphogenesis (BrM (show SMARCA2 Antibodies)) and induced synthesis of mRNAs for Ptch1 (show PTCH1 Antibodies) protein, epidermal growth factor (EGF (show EGF Antibodies)) and receptors of the ErbB (show EGFR Antibodies) receptors ErbB1 (show EGFR Antibodies), ErbB2 and ErbB3 (show ERBB3 Antibodies).

  7. ErbB2 receptor tyrosine kinase (show ERBB3 Antibodies) in AECs was activated by annexin V (show ANXA5 Antibodies), and blockade reduced the fibrotic potential of annexin V (show ANXA5 Antibodies)-treated AEC-conditioned medium.

  8. Disabling of the erbB (show EGFR Antibodies) pathway followed by IFNg (show IFNG Antibodies) modifies phenotype and enhances genotoxic eradication of breast tumors.

  9. Ptk6 (show PTK6 Antibodies) promotes ERBB2-induced mammary gland tumorigenesis in the mouse.

  10. PTPN12 (show PTPN12 Antibodies)-deficient, ErbB2-dependent breast cancer cells were more resistant to anoikis and had augmented migratory and invasive properties.

HER2 (ERBB2) Antigen Profile

Antigen Summary

This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized.

Alternative names and synonyms associated with HER2 (ERBB2)

  • v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (ERBB2) antibody
  • v-erb-b2 avian erythroblastic leukemia viral oncogene 2 (Erbb2) antibody
  • v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (ERBB2) antibody
  • v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (Erbb2) antibody
  • v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2) antibody
  • c-erbB2 antibody
  • c-neu antibody
  • CD340 antibody
  • Erbb-2 antibody
  • HER-2 antibody
  • HER-2/neu antibody
  • HER2 antibody
  • mKIAA3023 antibody
  • MLN 19 antibody
  • Neu antibody
  • NGL antibody
  • TKR1 antibody

Protein level used designations for ERBB2

receptor tyrosine-protein kinase erbB-2 , Avian erythroblastosis viral (v-erb-B2) oncogene homologue 2 (neuro/glioblastoma derived oncogene homolog) , C-erbB-2 , NEU proto-oncogene , epidermal growth factor receptor-related protein , p185erbB2 , p185neu , proto-oncogene NEU , proto-oncogene c-ErbB-2 , v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog , c-erb B2/neu protein , herstatin , metastatic lymph node gene 19 protein , neuro/glioblastoma derived oncogene homolog , neuroblastoma/glioblastoma derived oncogene homolog , proto-oncogene Neu , tyrosine kinase-type cell surface receptor HER2 , Neu oncogene , avian erythroblastosis oncogene B 2 , c-erbB-2 , erbB-2

GENE ID SPECIES
426130 Gallus gallus
24337 Rattus norvegicus
2064 Homo sapiens
13866 Mus musculus
403883 Canis lupus familiaris
Selected quality suppliers for anti-HER2 (ERBB2) Antibodies
Did you look for something else?